BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9548456)

  • 1. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.
    Topham DJ; Tripp RA; Doherty PC
    J Immunol; 1997 Dec; 159(11):5197-200. PubMed ID: 9548456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
    Baker MB; Podack ER; Levy RB
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):69-73. PubMed ID: 9118294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.
    Ostler T; Davidson W; Ehl S
    Eur J Immunol; 2002 Aug; 32(8):2117-23. PubMed ID: 12209623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
    Majlessi L; Bordenave G
    J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.
    Rafi AQ; Zeytun A; Bradley MJ; Sponenberg DP; Grayson RL; Nagarkatti M; Nagarkatti PS
    J Immunol; 1998 Sep; 161(6):3077-86. PubMed ID: 9743374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of murine (CD8+)CD27- T cells.
    Baars PA; Sierro S; Arens R; Tesselaar K; Hooibrink B; Klenerman P; van Lier RA
    Eur J Immunol; 2005 Nov; 35(11):3131-41. PubMed ID: 16220536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus-infected epithelium.
    Hou S; Doherty PC
    Eur J Immunol; 1995 Jan; 25(1):111-6. PubMed ID: 7843219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of protective immunity against influenza virus infection in mice without antibodies.
    Epstein SL; Lo CY; Misplon JA; Bennink JR
    J Immunol; 1998 Jan; 160(1):322-7. PubMed ID: 9551987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.
    Rode M; Balkow S; Sobek V; Brehm R; Martin P; Kersten A; Dumrese T; Stehle T; Müllbacher A; Wallich R; Simon MM
    J Virol; 2004 Nov; 78(22):12395-405. PubMed ID: 15507626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin protects against autoimmunity in lupus-prone mice.
    Peng SL; Moslehi J; Robert ME; Craft J
    J Immunol; 1998 Jan; 160(2):652-60. PubMed ID: 9551899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.